Doximity Cut to Sell on Rising OpenEvidence Competition; Price Target Maintained at $20, Signaling Downside RiskTip Ranks·Jul 21 at 05:55 AMDOCS-0.15%
Doximity Chief Accounting Officer Sitaram Siddharth disposes of 1,732 shares worth $38,150.64PUBT·Jul 20 at 09:16 AMDOCS-0.15%
Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety | DOCS Stock NewsStockTitan·Jul 15 at 05:26 AMDOCS-0.15%
Did Doximity Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR Newswire·Jul 3 at 11:32 AMDOCS-0.15%
Zscaler, Freshworks, and Sprinklr Shares Skyrocket, What You Need To KnowStock Story·Jul 1 at 12:40 PMFRSH+5.12%NOW+7.44%
Doximity, Inc. Stock 12‑Month Price Target Cut to $24.27, Implies 16% UpsideTradingView·Jun 29 at 12:20 PMDOCS-0.15%
This Liquidia Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Mondaybenzinga_article·Jun 29 at 07:49 AMDOCS-0.15%LQDA-3.16%
Doximity President Steven L. Zatz files initial beneficial ownership statementPUBT·Jun 18 at 03:26 PMDOCS-0.15%
Doximity (DOCS) Stock Valuation After Earnings Miss AI Spending Pressure And Legal InvestigationSimplywall·Jun 12 at 12:27 PMDOCS-0.15%
